Cowen Investment Management

Total investments

48

Average round size

83M

Portfolio companies

45

Rounds per year

9.60

Lead investments

1

Follow on index

0.06

Exits

41

Areas of investment
BiotechnologySoftwareHealth CareHealth DiagnosticsGeneticsManufacturingMedicalPharmaceuticalTherapeuticsBiopharma

Investments analytics

Analytics

Total investments
48
Lead investments
1
Exits
41
Rounds per year
9.60
Follow on index
0.06
Investments by industry
  • Biotechnology (38)
  • Health Care (24)
  • Therapeutics (13)
  • Medical (12)
  • Pharmaceutical (12)
  • Show 33 more
Investments by region
  • United States (42)
  • Canada (2)
  • United Kingdom (2)
  • France (1)
Peak activity year
2018
Number of Unicorns
2
Number of Decacorns
3
Number of Minotaurs
6

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
21
Avg. valuation at time of investment
477M
Group Appearance index
0.06
Avg. company exit year
18
Avg. multiplicator
0.79
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
True North Therapeutics 03 Dec 2015 Biotechnology, Health Care, Clinical Trials Late Stage Venture 40M United States, California, South San Francisco
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.